Short Bowel Syndrome Treatment Market Size, Trends, Share, Growth, and Regional Forecast, 2025 to 2032

Short Bowel Syndrome Treatment Market by Drug Class (Glucagon-like Peptide, Histamine Blockers, Proton Pump Inhibitors, Growth Hormone, Others), Distribution Channel, and Regional Analysis from 2025 to 2032

ID: PMRREP35947| 199 Pages | 11 Dec 2025 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Short Bowel Syndrome Treatment Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Product Adoption Analysis
    2. Regulatory Landscape
    3. Pipeline Analysis
    4. Value Chain Analysis
    5. Key Deals and Mergers
    6. PESTLE Analysis
    7. Porter’s Five Force Analysis
  4. Global Short Bowel Syndrome Treatment Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
    3. Global Short Bowel Syndrome Treatment Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Drug Class, 2019-2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
        1. Glucagon-like Peptide
        2. Histamine Blockers
        3. Proton Pump Inhibitors
        4. Growth Hormone
        5. Others
      4. Market Attractiveness Analysis: Drug Class
    4. Global Short Bowel Syndrome Treatment Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2019-2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
  5. Global Short Bowel Syndrome Treatment Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
    3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Short Bowel Syndrome Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. U.S.
      2. Canada
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Glucagon-like Peptide
      2. Histamine Blockers
      3. Proton Pump Inhibitors
      4. Growth Hormone
      5. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Attractiveness Analysis
  7. Europe Short Bowel Syndrome Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Glucagon-like Peptide
      2. Histamine Blockers
      3. Proton Pump Inhibitors
      4. Growth Hormone
      5. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Attractiveness Analysis
  8. East Asia Short Bowel Syndrome Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Glucagon-like Peptide
      2. Histamine Blockers
      3. Proton Pump Inhibitors
      4. Growth Hormone
      5. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Attractiveness Analysis
  9. South Asia & Oceania Short Bowel Syndrome Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Glucagon-like Peptide
      2. Histamine Blockers
      3. Proton Pump Inhibitors
      4. Growth Hormone
      5. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Attractiveness Analysis
  10. Latin America Short Bowel Syndrome Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Glucagon-like Peptide
      2. Histamine Blockers
      3. Proton Pump Inhibitors
      4. Growth Hormone
      5. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Attractiveness Analysis
  11. Middle East & Africa Short Bowel Syndrome Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Glucagon-like Peptide
      2. Histamine Blockers
      3. Proton Pump Inhibitors
      4. Growth Hormone
      5. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. OPKO Health, Inc.
        1. Overview
        2. Segments and Product
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Pfizer Inc.
      3. Takeda Pharmaceutical Company Limited
      4. Teva Pharmaceutical Industries Ltd.
      5. Ironwood
      6. Entera Bio Ltd.
      7. Zealand Pharma
      8. Emmaus Medical, Inc.
      9. EMD Serono
      10. OxThera
      11. Jaguar Health
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate